OurCrowd portfolio company ReWalk, developer of the FDA approved ReWalk exoskeleton device, was featured on Bloomberg Television’s “Bloomberg West.” In the interview, ReWalk Robotics CEO Larry Jasinksi discusses the company’s focus and growth strategy.
ReWalk raised $1,320,000 from OurCrowd investors in June 2013.
View the video on Bloomberg TV here.
![[Morphisec in PRWeb] Morphisec Rapidly Expands to More Than Four Million Endpoints Globally](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
